Hims & Hers Health, Inc. 8-K

What Happened
Hims & Hers Health, Inc. (HIMS) filed a Current Report on Form 8-K on March 11, 2026 disclosing that the company issued a press release on March 9, 2026 announcing a strategic shift for its U.S. weight loss business. The press release is furnished as Exhibit 99.1 to the 8-K and is incorporated by reference into the report. The filing was signed by CEO Andrew Dudum.

Key Details

• Filed Form 8-K on March 11, 2026 (Item 7.01: Regulation FD Disclosure; Item 9.01: Exhibits).
• Press release announcing the strategic shift dated March 9, 2026 (Exhibit 99.1).
• The press release is incorporated by reference into the 8-K.
• The filing was signed by Andrew Dudum, Chief Executive Officer.

Why It Matters
A strategic shift in Hims & Hers’ U.S. weight loss business could affect the company’s revenue mix, future growth prospects, and operational priorities. Retail investors should review the March 9, 2026 press release (Exhibit 99.1) for specifics on the change, and watch for follow-up disclosures (additional 8-Ks, investor presentations, or quarterly reports) that provide details on financial impacts, timelines, or restructuring actions.